Family Medicine

Eugenia South, MD, MSHP: COVID-19 and Nature

August 03, 2020

Video

Being outside is safer than being inside with a lot of people.

Eugenia South, MD, MSHP: Nature and the Role of the Provider

August 01, 2020

Video

Pediatrics is leading the way in prescribing nature.

Depression Patients More Likely to Suffer from Reward-Processing Impairments

July 31, 2020

Article

Impairment in reward-processing subcomponent categories is associated with tasks assessing option valuation, reward bias, and reinforcement learning.

Telescreening Programs Could Help Identify the Rates of Retinal Pathology

July 28, 2020

Article

A total of 115 of 200 examined eyes had some form of diabetic retinopathy in data presented at the ASRS 2020 virtual meeting.

Billing Codes Could be Useful in Capturing DME in Patients with NPDR

July 27, 2020

Article

In research presented at ASRS 2020, investigators found 56% of patients with PDR had a DME code, with a sensitivity of 85%.

Monthly or Quarterly Aflibercept Injections Appropriate for PDR Patients Without DME

July 27, 2020

Article

In a study presented at ASRS 2020, investigators find an improvement in DRSS is not correlated with a change in best corrected visual acuity.

Researchers Grade Online Information Accuracy for Ocular Gene Therapeutics

July 27, 2020

Article

Using the 4 JAMA benchmarks, investigators do not find any online articles that are entirely accurate and accountable.

Corticosteroids Show Efficacy Against Diabetic Macular Edema

July 27, 2020

Article

Steroids are often prescribed for diabetic macular edema following ineffectiveness of laser photocoagulation and anti-VEGF.

Phase 2 Wet AMD Study Halted Due to Toxicity Concerns

July 27, 2020

Article

In data presented virtually during the ASRS 2020 meeting, investigators find X-82 is non inferior in visual acuity outcomes.

Annual Alzheimer Disease Pipeline Shows Rapid Progress in Clinical Research

July 24, 2020

Article

As of February, 121 unique therapies are involved in clinical trials for Alzheimer disease, with putative disease-modifying agents targeting disease onset or progression accounting for the largest number.

x